𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Systemic liberation of interleukin-1β and interleukin-1 receptor antagonist in the perioperative phase of liver transplantation

✍ Scribed by Jörg Gerlach; Achim Jörres; Axel Berger; Michael Schön; Mark D. Smith; Roland Nohr; Peter Neuhaus

Publisher
Springer
Year
1996
Tongue
English
Weight
652 KB
Volume
9
Category
Article
ISSN
0934-0874

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interleukin-1β, interleukin-1 receptor a
Interleukin-1β, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: Relationship to occurrence and severity of rheumatoid arthritis
✍ Alain Cantagrel; Frédérique Navaux; Patrick Loubet-Lescoulié; Fathi Nourhashemi; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 2 views

## Objective: To test if interleukin-1beta (il-1beta), il-1 receptor antagonist (il-1ra), il-4, or il-10 gene polymorphisms could be used as markers of susceptibility or severity in rheumatoid arthritis (ra). ## Methods: The study included 108 patients with early ra followed up for 2 years and 12

Increased expression of mRNA encoding in
Increased expression of mRNA encoding interleukin-1β and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration
✍ Charlotta Eriksson; Roya Tehranian; Kerstin Iverfeldt; Bengt Winblad; Marianne S 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB 👁 1 views

Kainic acid, an analogue of glutamate, injected systemically to rats evokes seizures that are accompanied by nerve cell damage primarily in the limbic system. In the present study, we have analyzed the temporal profile of the expression of the cytokines interleukin-1␤ (IL-1␤) and IL-1 receptor antag

Role of intracellular interleukin-1 rece
Role of intracellular interleukin-1 receptor antagonist in skin carcinogenesis
✍ Eunhye La; Joyce E. Rundhaug; Susan M. Fischer 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

## Abstract Interleukin 1 (IL‐1) is a major mediator of inflammation and exerts pleiotropic effects on many systems. To elucidate the role of its endogenous inhibitor, intracellular IL‐1 receptor antagonist (icIL‐1Ra), in mouse skin, we produced an icIL‐1Ra–overexpressing skin carcinoma cell line (